Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: Relevance to risk assessment

Cancer Letters

Volumn 143, Issue 2, 1999, Pages 157-159

  Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Genotoxic carcinogen; Heterocyclic amine; Risk assessment

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; GLUTATHIONE TRANSFERASE; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CARCINOGENICITY; DIET; DRUG MILK LEVEL; FEMALE; GENOTOXICITY; MALE; NONHUMAN; PLACENTAL TRANSFER; PRECANCER; PRIORITY JOURNAL; RAT; RISK ASSESSMENT;

ANIMALS; CARCINOGENS; DIET; FOOD CONTAMINATION; GLUTATHIONE TRANSFERASE; HUMANS; LIVER; MALE; PRECANCEROUS CONDITIONS; QUINOXALINES; RATS; RATS, INBRED F344;

EID: 0032805849     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00117-2     Document Type: Article

References (10)

1. Kitano M., Ichihara T., Matsuda T., Wanibuchi H., Tamano S., Hagiwara A., Imaoka S., Funae Y., Shirai T., Fukushima S. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-indeced hepatic foci in the rat. Carcinogenesis. 19:1998;1475-1480.
2. Kitagawa T., Hino O., Nomura K., Sugano H. Dose-response studies on promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Carcinogenesis. 5:1984;1653-1656.
3. 2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis. 17:1996;1029-1034.
4. Ushiyama H., Wakabayashi K., Hirose M., Itoh H., Sugimura T., Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not in patients receiving parenteral alimentation. Carcinogenesis. 12:1991;1417-1422.
5. Yamashita K., Adachi M., Kato S., Nakagama H., Ochiai M., Wakabayashi K., Sato S., Nagao M., Sugimura T. DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration. Jpn. J. Cancer Res. 81:1990;470-476.
6. Kushida H., Wakabayashi K., Sato H., Katami M., Kurosaka R., Nagao M. Dose-response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett. 83:1994;31-35.
7. Reddy S., Wang C.X., Maruyama H. Effect of restricted caloric intake on azoxymethane-induced colon tumor incidence in male F344 rats. Cancer Res. 47:1987;1226-1228.
8. Ghoshal A., Snyderwine E. Excretion of food-derived heterocyclic amine carcinogens into breast milk of lactating rats and formation of DNA adducts in the newborn. Carcinogenesis. 14:1993;2199-2203.
9. Brittebo E.B., Karlsson A.I., Skog K.I., Jagerstad I.M. Transfer of the food mutagen PhIP to foetuses and newborn mice following maternal exposure. Food Chem. Toxicol. 32:1994;717-726.
10. Hasegawa R., Kimura J., Yaono M., Takahashi S., Kato T., Futakuchi M., Fukutake M., Fukutome K., Wakabayashi K., Sugimura T., Ito N., Shirai T. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague-Dawley rats. Cancer Res. 55:1995;4333-4338.